Literature DB >> 8667219

Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.

B J Copeland1, V Vogelsberg, N H Neff, M Hadjiconstantinou.   

Abstract

Incubation with either of the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and sn-1,2 dioctanoylglycerol (DiC8) decreased the uptake of dopamine into striatal synaptosomes, whereas the inactive phorbol ester 4 alpha-PMA had no effect. Washout of PMA and DiC8 failed to reverse the decrease in uptake. Kinetic analysis showed a decrease in the apparent V(max) for the transporter without changes in the K(m). Neither PMA nor DiC8 affected mazindol binding to the dopamine transporter. Preincubation with the protein kinase inhibitor staurosporine prevented the DiC8-induced decrease of dopamine uptake. Furthermore, the protein phosphatase inhibitor okadaic acid decreased dopamine uptake by itself and enhanced the DiC8-induced reduction of uptake. These findings support a role for protein kinase C in modulating dopamine transporter activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667219

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

Review 1.  Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.

Authors:  R Tapia; F Peña; C Arias
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity.

Authors:  Jae-Won Yang; Garret Larson; Lisa Konrad; Madhur Shetty; Marion Holy; Kathrin Jäntsch; Mirja Kastein; Seok Heo; Fatma Asli Erdem; Gert Lubec; Roxanne A Vaughan; Harald H Sitte; James D Foster
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.

Authors:  Lisa S Middleton; Subbu Apparsundaram; Kelley A King-Pospisil; Linda P Dwoskin
Journal:  Eur J Pharmacol       Date:  2006-10-19       Impact factor: 4.432

5.  Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.

Authors:  Jose A Morón; Alicia Brockington; Roy A Wise; Beatriz A Rocha; Bruce T Hope
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 6.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 7.  Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.

Authors:  Christopher L German; Michelle G Baladi; Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

8.  Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter.

Authors:  Ki-Hwan Lee; Mi-Young Kim; Dong-Hwan Kim; Yong-Sung Lee
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

9.  Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine.

Authors:  M Batchelor; J O Schenk
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 10.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.